The global fractional flow reserve market size is expected to reach USD 1,668.8 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.3% from 2023 to 2030. The widening proliferation of cardiovascular diseases coupled with mounting cases of diabetes in developed as well as developing economies is escalating the growth of the market. Furthermore, the launch of novel devices in the fractional flow reserve (FFR) market such as guidewires and monitoring systems are also anticipated to aid market growth. For instance, in May 2019, Philips launched the IntraSight interventional applications platform. This platform offers a comprehensive unit of IVUS, FFR, IFR, and co-registration modalities to speed up routine procedures and simplify complex interventions.
In an independent study by SCAI in 2019, it was observed that FFR possesses the capability to decide the treatment plan for Acute Coronary Syndrome (ACS) which could be either PCI (Percutaneous Coronary Intervention) or CABG (Coronary Artery Bypass Grafting). This is anticipated to help the physicians and provide an effective treatment plan to patients, thereby increasing adoption of the same in the coming five years.
The COVID-19 pandemic is expected to have a positive impact on the market growth owing to growing initiatives by market players, government support, and others. For instance, in July 2020, Acist Medical Systems, Inc., a Bracco Group Corporation, proclaimed the international introduction of the Navvus II rapid exchange FFR microcatheter, a second-generation device for use with the firm's RXi rapid exchange FFR system in percutaneous coronary intervention procedures. Moreover, consolidation activities, such as the acquisition of St. Jude by Abbott in 2017 in order to increase its foothold in the cardiovascular devices market, are likely to keep the market highly competitive and thereby augur well for the overall market growth.
Request a free sample copy or view report summary: Fractional Flow Reserve Market Report
The FFR guidewires segment dominated the market with the largest revenue share of over 55% in 2022. This is attributed to their extensive usage in diagnostic cardiovascular procedures and coronary arteries.
The FFR monitoring systems segment is expected to grow at the fastest CAGR of 9.5% over the forecast period.
The single-vessel CAD segment dominated the market and held the largest revenue share of around 50% in 2022. This is attributed to the extensive use of the device in CAD cases, combined with the increasing number of elderly populations.
The multi-vessel coronary artery disease CAD segment is expected to grow at the fastest CAGR of 9.5% over the forecast period, as this disease is a matured phase of single-vessel CAD.
North America dominated the fractional flow reserve market and held the largest market share of around 40% in 2022. This is attributed to favorable government policies aimed at promoting the adoption of medical devices and the presence of a well-established healthcare infrastructure.
Asia Pacific is expected to grow at the fastest CAGR of 9.8% over the forecast period due to increased diabetes and cardiovascular disease cases and rising disposable income.
Grand View Research has segmented the global fractional flow reserve market report based on product, application, and region:
Fractional Flow Reserve Product Outlook (Revenue, USD Million, 2018 - 2030)
FFR Guidewires
FFR Monitoring Systems
Fractional Flow Reserve Application Outlook (Revenue, USD Million, 2018 - 2030)
Multi-vessel CAD
Single-vessel CAD
Fractional Flow Reserve Regional Outlook (Revenue in USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Fractional Flow Reserve Market
Opsens Medical
Abbott Laboratories
Boston Scientific
ACIST Medical Systems
Koninklijke Philips N.V.
Opsens, Inc.
HeartFlow, Inc.
Siemens Healthineers
Pie Medical Imaging
CathWorks
Medis Medical Imaging Systems BV
"The quality of research they have done for us has been excellent..."